tetano
Editor, Senior Moderator
BMC Pulm Med
. 2024 Jun 25;24(1):298.
doi: 10.1186/s12890-024-03118-2. End-expiratory lung volumes as a potential indicator for COVID-19 associated acute respiratory distress syndrome: a retrospective study
Shengyu Hao[SUP] #[/SUP][SUP] 1 [/SUP], Yilin Wei[SUP] #[/SUP][SUP] 1 2 [/SUP], Yuxian Wang[SUP] #[/SUP][SUP] 1 [/SUP], Yaxiaerjiang Muhetaer[SUP] 1 [/SUP], Chujun Zhou[SUP] 1 [/SUP], Songjie Qiong[SUP] 1 [/SUP], Pan Jiang[SUP] 3 [/SUP], Ming Zhong[SUP] 4 [/SUP]
Affiliations
Background: End-expiratory lung volume (EELV) has been observed to decrease in acute respiratory distress syndrome (ARDS). Yet, research investigating EELV in patients with COVID-19 associated ARDS (CARDS) remains limited. It is unclear whether EELV could serve as a potential metric for monitoring disease progression and identifying patients with ARDS at increased risk of adverse outcomes.
Study design and methods: This retrospective study included mechanically ventilated patients diagnosed with CARDS during the initial phase of epidemic control in Shanghai. EELV was measured using the nitrogen washout-washin technique within 48 h post-intubation, followed by regular assessments every 3-4 days. Chest CT scans, performed within a 24-hour window around each EELV measurement, were analyzed using AI software. Differences in patient demographics, clinical data, respiratory mechanics, EELV, and chest CT findings were assessed using linear mixed models (LMM).
Results: Out of the 38 patients enrolled, 26.3% survived until discharge from the ICU. In the survivor group, EELV, EELV/predicted body weight (EELV/PBW) and EELV/predicted functional residual capacity (EELV/preFRC) were significantly higher than those in the non-survivor group (survivor group vs. non-survivor group: EELV: 1455 vs. 1162 ml, P = 0.049; EELV/PBW: 24.1 vs. 18.5 ml/kg, P = 0.011; EELV/preFRC: 0.45 vs. 0.34, P = 0.005). Follow-up assessments showed a sustained elevation of EELV/PBW and EELV/preFRC among the survivors. Additionally, EELV exhibited a positive correlation with total lung volume and residual lung volume, while demonstrating a negative correlation with lesion volume determined through chest CT scans analyzed using AI software.
Conclusion: EELV is a useful indicator for assessing disease severity and monitoring the prognosis of patients with CARDS.
Keywords: Acute respiratory distress syndrome; COVID-19; End-expiratory lung volume; Mechanical ventilation.
. 2024 Jun 25;24(1):298.
doi: 10.1186/s12890-024-03118-2. End-expiratory lung volumes as a potential indicator for COVID-19 associated acute respiratory distress syndrome: a retrospective study
Shengyu Hao[SUP] #[/SUP][SUP] 1 [/SUP], Yilin Wei[SUP] #[/SUP][SUP] 1 2 [/SUP], Yuxian Wang[SUP] #[/SUP][SUP] 1 [/SUP], Yaxiaerjiang Muhetaer[SUP] 1 [/SUP], Chujun Zhou[SUP] 1 [/SUP], Songjie Qiong[SUP] 1 [/SUP], Pan Jiang[SUP] 3 [/SUP], Ming Zhong[SUP] 4 [/SUP]
Affiliations
- PMID: 38918752
- DOI: 10.1186/s12890-024-03118-2
Background: End-expiratory lung volume (EELV) has been observed to decrease in acute respiratory distress syndrome (ARDS). Yet, research investigating EELV in patients with COVID-19 associated ARDS (CARDS) remains limited. It is unclear whether EELV could serve as a potential metric for monitoring disease progression and identifying patients with ARDS at increased risk of adverse outcomes.
Study design and methods: This retrospective study included mechanically ventilated patients diagnosed with CARDS during the initial phase of epidemic control in Shanghai. EELV was measured using the nitrogen washout-washin technique within 48 h post-intubation, followed by regular assessments every 3-4 days. Chest CT scans, performed within a 24-hour window around each EELV measurement, were analyzed using AI software. Differences in patient demographics, clinical data, respiratory mechanics, EELV, and chest CT findings were assessed using linear mixed models (LMM).
Results: Out of the 38 patients enrolled, 26.3% survived until discharge from the ICU. In the survivor group, EELV, EELV/predicted body weight (EELV/PBW) and EELV/predicted functional residual capacity (EELV/preFRC) were significantly higher than those in the non-survivor group (survivor group vs. non-survivor group: EELV: 1455 vs. 1162 ml, P = 0.049; EELV/PBW: 24.1 vs. 18.5 ml/kg, P = 0.011; EELV/preFRC: 0.45 vs. 0.34, P = 0.005). Follow-up assessments showed a sustained elevation of EELV/PBW and EELV/preFRC among the survivors. Additionally, EELV exhibited a positive correlation with total lung volume and residual lung volume, while demonstrating a negative correlation with lesion volume determined through chest CT scans analyzed using AI software.
Conclusion: EELV is a useful indicator for assessing disease severity and monitoring the prognosis of patients with CARDS.
Keywords: Acute respiratory distress syndrome; COVID-19; End-expiratory lung volume; Mechanical ventilation.